ConductScience.org, home

Paper31574418

Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).

Rivin Del Campo E and 16 others. Eur J Cancer, 2019. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). Papers, record 31574418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31574418

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
PubMed
Journal
Eur J Cancer
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.64
iCite
Revised in PubMed
2026-10-09
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rivin Del Campo EEleonor
2Matzinger OOscar
3Haustermans KKarin
4Peiffert DDidier
5Glynne-Jones RRobert
6Winter KAKathryn A
7Konski AAAndre A
8Ajani JAJaffer A
9Bosset JFJean-François
10Hannoun-Levi JMJean-Michel
11Puyraveau MMarc
12Chakravarthy ABA Bapsi
13Meadows HHelen
14Northover JJohn
15Collette LLaurence
16Christiaens MMelissa
17Maingon PPhilippe

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anus NeoplasmsMajor topic
ChemoradiotherapyMajor topic
Clinical Trials, Phase II as TopicMajor topic
Clinical Trials, Phase III as TopicMajor topic
FluorouracilMajor topic
MitomycinMajor topic
Combined Modality Therapy
Humans
Neoplasm Recurrence, Local
Radiotherapy Dosage
Treatment Outcome

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U10 CA180820NCI NIH HHSUnited StatesU10CA180820PubMed and NIHNIH RePORTER
U10 CA180822NCI NIH HHSUnited StatesU10CA180822PubMed and NIHNIH RePORTER
U10 CA180868NCI NIH HHSUnited StatesU10CA180868PubMed and NIHNIH RePORTER
UG1 CA233270NCI NIH HHSUnited StatesUG1CA233270PubMed and NIHNIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130128811Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.Med Oncol2018https://conductscience.org/library/papers/30128811PubMed
222529257Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.J Clin Oncol2012https://conductscience.org/library/papers/22529257PubMed
330773194Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence.Radiother Oncol2019https://conductscience.org/library/papers/30773194PubMed
430172453Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).Radiother Oncol2018https://conductscience.org/library/papers/30172453PubMed
529755663The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.Oncotarget2018https://conductscience.org/library/papers/29755663PubMed
624721444Chemoradiotherapy for squamous cell cancer of the anal canal: a systematic review.Clin Oncol (R Coll Radiol)2014https://conductscience.org/library/papers/24721444PubMed
720368838Radical radiotherapy for locally advanced cancer of uterine cervix.Cancer Res Treat2004https://conductscience.org/library/papers/20368838PubMed
812873670Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.Int J Radiat Oncol Biol Phys2003https://conductscience.org/library/papers/12873670PubMed
925239441Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.Eur J Surg Oncol2014https://conductscience.org/library/papers/25239441PubMed
108934049A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.Clin Oncol (R Coll Radiol)1996https://conductscience.org/library/papers/8934049PubMed
1134400269
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.
Int J Radiat Oncol Biol Phys2022https://conductscience.org/library/papers/34400269PubMed
1220354531Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).Br J Cancer2010https://conductscience.org/library/papers/20354531PubMed
1326995081Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers.Crit Rev Oncol Hematol2016https://conductscience.org/library/papers/26995081PubMed
1421450408Chemotherapy/chemoradiation in anal cancer: a systematic review.Cancer Treat Rev2011https://conductscience.org/library/papers/21450408PubMed
1512837978Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.Oncology2003https://conductscience.org/library/papers/12837978PubMed
1631167658MR-guidance in clinical reality: current treatment challenges and future perspectives.Radiat Oncol2019https://conductscience.org/library/papers/31167658PubMed
1730201015Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.Radiat Oncol2018https://conductscience.org/library/papers/30201015PubMed
1829527660Impact of socioeconomic status on survival for patients with anal cancer.Cancer2018https://conductscience.org/library/papers/29527660PubMed
199069302Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications.Int J Radiat Oncol Biol Phys1997https://conductscience.org/library/papers/9069302PubMed
2024401669Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.Am J Clin Oncol2016https://conductscience.org/library/papers/24401669PubMed

See all 54 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42583088Biological features of squamous cell carcinoma of the anus-a deep dive review.ESMO Gastrointest Oncol2026https://conductscience.org/library/papers/42583088PubMed
42471955Simultaneous integrated boost vs sequential boost chemoradiotherapy in anal squamous cell carcinoma: Association with improved disease-free survival and the role of treatment delivery parameters.Clin Transl Radiat Oncol2026https://conductscience.org/library/papers/42471955PubMed
41588386Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy.BMC Cancer2026https://conductscience.org/library/papers/41588386PubMed
37632562A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/37632562PubMed
35402741Acceptance of physical activity monitoring in cancer patients during radiotherapy, the GIROfit phase 2 pilot trial.Tech Innov Patient Support Radiat Oncol2022https://conductscience.org/library/papers/35402741PubMed
33430396MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/33430396PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TRAF3IP210758PubTator's text mininghttps://conductscience.org/library/genes/10758

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31574418

GET https://conductscience.org/api/papers/v1/31574418/references?page=2